Patents by Inventor Rajarshi Pal

Rajarshi Pal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240152797
    Abstract: The disclosure relates to a method for generating a custom predictive model, the method comprising receiving a plurality of datasets; identifying a plurality of features affecting prediction of a predictive model; determining an importance score for each of the plurality of features; determining a probability of prediction for each dataset from the plurality of the datasets based on one or more features from the plurality of features for the prediction of each dataset, and respective importance scores for the one or more features; and training a custom predictive model using the plurality of datasets with the probabilities, the respective features, and the respective importance scores.
    Type: Application
    Filed: November 7, 2022
    Publication date: May 9, 2024
    Inventors: Rahul Verma, Gunjit Bedi, Shubhro Pal, Darren Saumur, Rajarshi Sanyal, Sibasis Patro
  • Publication number: 20220162563
    Abstract: Disclosed is an in-vitro protocol for differentiating human induced pluripotent stem cells (hiPSCs) or human embryonic stem cells (hESC) to give rise to a definitive endoderm, followed by progression into anteriorized foregut endoderm that has the ability to give rise to both proximal and distal lung epithelial cells. The protocol not only offers great opportunities for the study of human development but also have tremendous potential for future clinical cell-based therapies. The protocol outlined here is used to differentiate hiPSCs into lung epithelial cell types through a process that faithfully recapitulates the stepwise events observed in-vivo. The was followed with the working cell bank of an hiPSC line made under current Good Manufacturing Practice (cGMP) conditions, a necessary step for the future clinical application of these cells.
    Type: Application
    Filed: November 5, 2020
    Publication date: May 26, 2022
    Inventors: Rajarshi PAL, Harshini Bava SURENDRAN, Mohanapriya RAJAMOORTHY
  • Patent number: 11168301
    Abstract: A unified cell differentiation protocol for obtaining photoreceptor cells, retinal pigment epithelium, and 3D retinal organoid from pluripotent stem cells is described. Also described are photoreceptor cells, retinal pigmented epithelium, and 3D retinal organoid obtained from pluripotent stem cells. Also described are a pharmaceutical composition and a medicament containing the photoreceptor cells, retinal pigment epithelium, and 3D retinal organoid as described.
    Type: Grant
    Filed: October 5, 2018
    Date of Patent: November 9, 2021
    Assignee: EYESTEM RESEARCH PRIVATE LIMITED
    Inventors: Rajarshi Pal, Rajani Battu, Reena Rathod, Harshini Surendran, Kapil Bharti, Deepak Lamba, Dhruv Sareen, Mahendra Rao, Sushma Nanjunda Swamy, Vijay Bhaskar Konala Reddy, Mohanapriya Rajamoorthy
  • Publication number: 20200224159
    Abstract: A unified cell differentiation protocol for obtaining photoreceptor cells, retinal pigment epithelium, and 3D retinal organoid from pluripotent stem cells is described. Also described are photoreceptor cells, retinal pigmented epithelium, and 3D retinal organoid obtained from pluripotent stem cells. Also described are a pharmaceutical composition and a medicament containing the photoreceptor cells, retinal pigment epithelium, and 3D retinal organoid as described.
    Type: Application
    Filed: October 5, 2018
    Publication date: July 16, 2020
    Inventors: Rajarshi PAL, Rajani BATTU, Reena RATHOD, Harshini SURENDRAN, Kapil BHARTI, Deepak LAMBA, Dhruv SAREEN, Mahendra RAO, Sushma NANJUNDA SWAMY, Vijay Bhaskar KONALA REDDY, Mohanapriya RAJAMOORTHY
  • Patent number: 7811817
    Abstract: Purified preparations of human embryonic stem cells with certain population-specific characteristics are disclosed. This preparation is characterized by the positive expression of the following pluripotent cell surface markers: SSEA-1 (?); SSEA-4 (+); TRA-1-60 (+); TRA-1-81 (+); alkaline phosphatase (+), as well as a set of ES cell markers including Oct-4, Nanog, Rex1, Sox2, Thy1, FGF4, ABCG2, Dppa5, UTF1, Cripto1, hTERT, Connexin-43 and Connexin-45. The cells of the preparation are negative for lineage specific markers like Keratin 8, Sox-1, NFH (ectoderm), MyoD, brachyury, cardiac-actin (mesoderm), HNF-3 beta, albumin, and PDX1 (endoderm). The cells of the preparation are human embryonic stem cells, have normal karyotypes, exhibit high telomerase activity and continue to proliferate in an undifferentiated state after continuous culture for over 40 passages.
    Type: Grant
    Filed: May 17, 2006
    Date of Patent: October 12, 2010
    Assignee: Reliance Life Sciences Pvt. Ltd.
    Inventors: Arundhati Mandal, Shabari Tipnis, Geeta Ravindran, Jayant Kulkarni, Ameet Patki, Rajarshi Pal, Bipasha Bose, Alam Firdos Kahn, Aparna Khanna
  • Publication number: 20060286544
    Abstract: Purified preparations of human embryonic stem cells with certain population-specific characteristics are disclosed. This preparation is characterized by the positive expression of the following pluripotent cell surface markers: SSEA-1 (?); SSEA-4 (+); TRA-1-60 (+); TRA-1-81 (+); alkaline phosphatase (+), as well as a set of ES cell markers including Oct-4, Nanog, Rex1, Sox2, Thy1, FGF4, ABCG2, Dppa5, UTF1, Criptol, hTERT, Connexin-43 and Connexin-45. The cells of the preparation are negative for lineage specific markers like Keratin 8, Sox-1, NFH (ectoderm), MyoD, brachyury, cardiac-actin (mesoderm), HNF-3 beta, albumin, and PDX1 (endoderm). The cells of the preparation are human embryonic stem cells, have normal karyotypes, exhibit high telomerase activity and continue to proliferate in an undifferentiated state after continuous culture for over 40 passages.
    Type: Application
    Filed: May 17, 2006
    Publication date: December 21, 2006
    Inventors: Arundhati Mandal, Shabari Tipnis, Geeta Ravindran, Jayant Kulkarni, Ameet Patki, Rajarshi Pal, Bipasha Bose, Firdos Khan, Aparna Khanna